The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 346:2079-2082 June 27, 2002 Number 26
NextNext

Decision Making with Cardiac Troponin Tests

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Aviles, R. J.
-PubMed Citation
After the loss of integrity of cardiac myocyte membranes, intracellular macromolecules (cardiac biologic markers) diffuse into the cardiac interstitium, lymphatics, and microvasculature; eventually, they are detected in the peripheral circulation. The release kinetics of the various cardiac biologic markers depend in part on their location in the myocyte, their molecular weight, and the route by which they are cleared from the circulation. Cardiac-specific troponins are useful not only because they come close to fulfilling many of the criteria for an ideal biologic marker, but also because they convey prognostic information and can help frame therapeutic decisions regarding patients with acute . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.